Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C van de Loo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Langenbecks Archiv Fur Chirurgie|November 1, 1977
[Medical treatment of venous thromboembolism (author's transl)]J C van de Loo
La Ricerca in Clinica E in Laboratorio|October 1, 1989
Predictive value of factors of the hemostatic system in screening procedures for coronary artery diseaseJ C van de Loo
Annals of Epidemiology|July 1, 1992
The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris GroupF Haverkate, S G Thompson, J C van de Loo
The New England Journal of Medicine|March 9, 1995
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study GroupS G Thompson, J Kienast, S D Pyke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1996
Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectorisS G Thompson, C Fechtrup, E Squire, et al.
Thrombosis and Haemostasis|October 31, 1983
Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinaseW Theiss, F Asbeck, A Kriessmann, et al.
Thrombosis and Haemostasis|April 8, 1998
Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteriesJ Kienast, T Padró, M Steins, et al.
Thrombosis and Haemostasis|October 31, 1983
Controlled multicenter pilot study of urokinase- heparin and streptokinase in deep vein thrombosisJ C van de Loo, A Kriessmann, G Trübestein, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Langenbecks Archiv Fur Chirurgie|November 1, 1977
[Medical treatment of venous thromboembolism (author's transl)]J C van de Loo
La Ricerca in Clinica E in Laboratorio|October 1, 1989
Predictive value of factors of the hemostatic system in screening procedures for coronary artery diseaseJ C van de Loo
Annals of Epidemiology|July 1, 1992
The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris GroupF Haverkate, S G Thompson, J C van de Loo
The New England Journal of Medicine|March 9, 1995
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study GroupS G Thompson, J Kienast, S D Pyke, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1996
Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectorisS G Thompson, C Fechtrup, E Squire, et al.
Thrombosis and Haemostasis|October 31, 1983
Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinaseW Theiss, F Asbeck, A Kriessmann, et al.
Thrombosis and Haemostasis|April 8, 1998
Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteriesJ Kienast, T Padró, M Steins, et al.
Thrombosis and Haemostasis|October 31, 1983
Controlled multicenter pilot study of urokinase- heparin and streptokinase in deep vein thrombosisJ C van de Loo, A Kriessmann, G Trübestein, et al.
Pageof 1